Z Squared Inc. (NasdaqGM: ZSQR)
Health Care · Biotechnology · US
$3.65
-7.36% today · -73.1% 1Y
Z Squared Inc. (NasdaqGM: ZSQR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $208.82M and employs 6 people.
Over the last twelve months the share price has lost 73.1%, trading between 3.83 and 21.41.
ZSQR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $208.82M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -5.10
- Dividend yield
- —
- Beta (5Y)
- -0.19
- 52-week high
- $21.41
- 52-week low
- $3.83
- Avg volume (3M)
- —
- Shares outstanding
- 53.00M
- Employees
- 6
- Next earnings
- —
About Z Squared Inc.
Z Squared Inc. operates as an integrated computing infrastructure company, deploying and managing advanced computing equipment across its facilities in North Carolina, South Carolina, and Iowa. The firm diligently oversees and optimizes its extensive network of specialized hardware. This comprehensive approach incorporates dynamic power management strategies, real-time analytics dashboards for performance monitoring, and an internal program dedicated to repair and lifecycle management. These measures collectively aim to maximize the operational efficiency of their hardware assets and minimize capital expenditure. Established in 2022, Z Squared Inc. has its corporate base in Fort Lauderdale, Florida.
- Founded
- 2022
- Listed since
- Dec 17, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.